Bionic prostheses & neuroprosthetics
Prosthetic devices that replace a lost limb's function through AI-driven control, touch sensing and direct skeletal attachment — dexterous touch-sensing hands, AI neural prosthetic control, myoelectric pattern recognition and osseointegrated prostheses: Psyonic, Atom Limbs and Coapt in the US, Ottobock and Integrum in Europe, and BrainCo (BrainRobotics) in China.
1 · What it gives
Bionic prostheses and neuroprosthetics replace a lost limb’s function using AI-driven control, dexterous touch sensing and, increasingly, direct skeletal attachment rather than a traditional socket. Psyonic’s Ability Hand became one of the first commercial dexterous hands officially integrated into NVIDIA Isaac Lab, announced at NVIDIA GTC 2026, and the company partnered with ABB Robotics to study whether its prosthetic touch-sensor data can improve industrial robot grasping. Atom Limbs develops an AI-driven bionic arm combining neural interfaces and advanced robotics to restore natural, intuitive arm and hand function. Coapt secured a new CMS reimbursement code (L6700) for upper-limb pattern recognition prostheses in January 2025 and was acquired by Hanger, Inc. in 2025, and its COMPLETE CONTROL System Gen2 uses AI and machine learning for prosthesis control. Ottobock introduced its next-generation speedhand myoelectric prosthetic arm solution, with modular wrist options and a companion connectgrip app, and presented its prosthetics and orthotics portfolio at OTWorld 2026. Integrum’s OPRA implant system, an osseointegration technology that anchors a prosthesis directly to bone, demonstrated superior treatment outcomes in a two-year follow-up study by Walter Reed National Military Medical Center, and the company is expanding implant system access in Ukraine. In China, BrainCo’s BrainRobotics division expects bionic hand sales to grow significantly, per Chinese trade press coverage.
The key directions of bionic prostheses & neuroprosthetics are:
- Dexterous touch-sensing hands (Dexterous Touch-Sensing Hands): high-degree-of-freedom prosthetic hands with integrated touch sensors, dexterous enough for robotics research applications beyond prosthetic use — Psyonic’s Ability Hand.
- AI neural prosthetic control (AI Neural Prosthetic Control): neural-interface-driven bionic limbs using AI to restore natural, intuitive movement — Atom Limbs.
- Myoelectric pattern recognition (Myoelectric Pattern Recognition): AI/machine-learning control systems that decode muscle-signal patterns for intuitive multi-grip prosthetic control, now with dedicated reimbursement coding — Coapt’s COMPLETE CONTROL System, and Ottobock’s speedhand myoelectric arm.
- Osseointegrated prostheses (Osseointegrated Prostheses): implants that anchor a prosthetic limb directly to bone rather than a socket, validated in military rehabilitation populations — Integrum’s OPRA system.
Sectoral value chain#
[control/attachment technology design] ──> [preclinical/clinical validation] ──> [regulatory clearance (FDA/MDR/NMPA)]
│
(fitting/reimbursement coding)
│
▼
[capability/indication expansion] <─── [user outcome data generation] <─────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Control/Attachment Technology Design | designing the prosthetic’s control interface (myoelectric pattern recognition, neural interface) or bone-anchoring mechanism (osseointegration) | In: residual-limb physiology, control algorithm. Out: prosthetic control/attachment system. |
| Preclinical/Clinical Validation | testing dexterity, control accuracy and, for osseointegration, bone-implant stability in trial and rehabilitation-center populations | In: prototype device, study protocol. Out: clinical performance data. |
| Regulatory Clearance | FDA 510(k)/PMA, EU MDR conformity assessment, or NMPA registration of the prosthetic device | In: clinical validation data. Out: cleared/registered device. |
| Fitting/Reimbursement Coding | a prosthetist fits the device to the individual user, supported by a specific insurance/CMS reimbursement code | In: cleared device, patient assessment. Out: fitted, reimbursable prosthesis. |
| User Outcome Data | data on grip success, daily-use adoption and, for osseointegration, long-term implant stability are collected | In: fitted-user cohort. Out: outcome evidence. |
| Capability/Indication Expansion | outcome evidence supports new control capabilities, market expansion or adjacent applications such as robotics research | In: outcome evidence. Out: expanded capability/market. |
Cross-cutting technologies of the sector:
- Dexterous touch sensing (Dexterous Touch-Sensing Hands): integrated tactile sensors giving a prosthetic hand touch feedback precise enough to inform robotic manipulation research, not just prosthetic use.
- AI/neural control decoding (AI Neural Prosthetic Control, Myoelectric Pattern Recognition): machine-learning algorithms that decode neural or muscle-signal patterns into multi-grip, intuitive prosthetic movement.
- Osseointegration (Osseointegrated Prostheses): direct bone anchoring of a prosthesis, eliminating socket-related discomfort and improving proprioceptive feedback.
2 · What it replaces 0 · matched by industry
No graded substitution linked yet.
3 · How to implement 6 steps
- 1Control and attachment technology designThe prosthetic’s control interface (myoelectric pattern recognition, neural interface) or bone-anchoring mechanism (osseointegration) is designed, as with Coapt’s pattern-recognition algorithms versus Integrum’s OPRA osseointegration hardware.
- 2Preclinical and clinical validationTesting & analyticsDexterity, control accuracy and, for osseointegration, bone-implant stability are tested in trial and rehabilitation-center populations, the evidence base behind Integrum’s Walter Reed two-year follow-up study.Who can do this step matched automatically
- 3Regulatory clearanceRegulatory & certificationThe device clears FDA 510(k)/PMA, EU MDR conformity assessment, or NMPA registration, with Coapt’s control system and Integrum’s implant both progressing through their respective device-class pathways.Registration in Russia / EAEU: Regulation
- 4Fitting and reimbursement codingA prosthetist fits the device to the individual user, supported by a specific insurance/CMS reimbursement code, as with Coapt’s new L6700 code specifically enabling pattern-recognition-control reimbursement.
- 5User outcome data generationData on grip success, daily-use adoption and, for osseointegration, long-term implant stability are collected, exemplified by Integrum’s Walter Reed outcomes data and Psyonic’s touch-sensor data now feeding into ABB’s robotics research.
- 6Capability and indication expansionFermentation & cultivationOutcome evidence supports new control capabilities, market expansion or adjacent applications, the pattern behind Psyonic’s NVIDIA Isaac Lab/ABB robotics expansion beyond prosthetic use, Integrum’s Ukraine market expansion, and BrainCo’s reported bionic-hand sales growth in China.Who can do this step matched automatically✓ ISO 9001 500 m3“Technology: microbial fermentation with ~500 m3 fermentation capacity; 15+ patents; developed/upscaled probiotic production technologies.”✓ ISO 9001 75,000 tons industrial scale“Henan Jindan Lactic Acid Technology Co., Ltd.(金丹科技,SZ300829)研发、生产和销售L-乳酸及乳酸盐(乳酸钠、乳酸钙)等发酵产品,产品用于食品、饲料、生物降解材料(PLA等原料)、工业与医药等领域;公司采用现代微生物发酵技术,拥有自研菌种育种体系及乳酸制备、提纯等核心工艺,并具备国家级研发平台与多项专利。公 …”Spiber Japan✓ ISO 9001 industrial scale“By harnessing the power of precision fermentation, Spiber engineers proteins at the molecular level, resulting in versatile materials that can be tailored to specific needs.”
4 · Who delivers
Matched suppliers (matched automatically)
| CHITOSE | Japan | Research / RTO | active |
| UMITRON (SG subsidiary) | Singapore | Not classified | active |
| Sappi (JSE: SAP) | South Africa | Producer | active |
| Singrow | Singapore | Producer | active |
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Psyonic | 🇺🇸 USA | Ability Hand | NVIDIA Isaac Lab integration, ABB robotics collaboration | growth |
| Atom Limbs | 🇺🇸 USA | AI-driven bionic arm | Neural interfaces, advanced robotics | growth |
| Coapt | 🇺🇸 USA | COMPLETE CONTROL System Gen2 | CMS L6700 reimbursement code, acquired by Hanger | growth |
| Ottobock | 🇩🇪 Germany | speedhand myoelectric arm | Modular wrist, connectgrip app | growth |
| Integrum | 🇸🇪 Sweden | OPRA osseointegration implant | Walter Reed-validated, Ukraine expansion | growth |
| BrainCo (BrainRobotics) | 🇨🇳 China | Intelligent bionic hand | Strong reported sales growth | growth |
5 · Rules & route to market
United States
The US hosts the leading concentration of bionic prosthetics innovation, spanning dexterous touch-sensing hands, AI-driven neural interfaces and myoelectric pattern-recognition control with new reimbursement pathways.
Psyonic, Atom Limbs, Coapt, FDA#
- Psyonic: its Ability Hand became one of the first commercial dexterous hands officially integrated into NVIDIA Isaac Lab, announced at NVIDIA GTC 2026, and the company partnered with ABB Robotics to study whether its prosthetic touch-sensor data can improve industrial robot grasping.
- Atom Limbs: develops an AI-driven bionic arm combining neural interfaces and advanced robotics to restore natural, intuitive arm and hand function.
- Coapt: secured a new CMS reimbursement code (L6700) for upper-limb pattern recognition prostheses in January 2025 and was acquired by Hanger, Inc. in 2025; its COMPLETE CONTROL System Gen2 uses AI and machine learning for prosthesis control.
- FDA framework: bionic prostheses clear FDA 510(k)/PMA per device class, while reimbursement coverage runs through separate CMS HCPCS coding, as with Coapt’s new L6700 code specifically for pattern-recognition control.
European Union
Germany and Sweden anchor Europe’s bionic prosthetics capacity, spanning the world’s leading myoelectric prosthetics maker and a specialized osseointegration implant system with military rehabilitation validation.
Ottobock, Integrum, MDR#
- Ottobock (Germany): introduced its next-generation speedhand myoelectric prosthetic arm solution, with modular wrist options and a companion connectgrip app, and presented its prosthetics and orthotics portfolio at OTWorld 2026.
- Integrum (Sweden; Nasdaq Stockholm: INTEG B): its OPRA implant system, an osseointegration technology that anchors a prosthesis directly to bone, demonstrated superior treatment outcomes in a two-year follow-up study by Walter Reed National Military Medical Center, and the company is expanding implant system access in Ukraine.
- MDR framework: bionic prostheses and osseointegration implants sold in the EU require conformity assessment under the Medical Device Regulation (MDR 2017/745), with Integrum’s implant system a Class III device under this framework.
China
China’s confirmed bionic prosthetics activity centers on a Hangzhou-based AI bionic hand maker reporting strong sales growth expectations.
BrainCo (BrainRobotics), NMPA#
- BrainCo (Zhejiang Qiangnao Technology / 强脑科技; BrainRobotics division): its intelligent bionic hand is expected to see bionic hand sales grow significantly this year, per Chinese trade press including Lianhe Zaobao coverage, and the product is exhibited at China’s assistive-technology (福祉) expo circuit.
- NMPA pathway: bionic prosthetic devices register with NMPA as medical devices, with control-system software components subject to the same registration as the physical device.
6 · Money: tenders & grants
| Grant | Capacity building for extending product lifecycles through repair and refurbishment European Commission · EU | Sep 22, 2027 341 days |
| Grant | Circular innovative advanced materials: facilitating the transition from design to markets (RIA) (Innovative … European Commission · EU | Feb 2, 2027 109 days |
| Grant | Deploying circular systemic solutions through living labs in cities and regions (Circular Cities and Regions … European Commission · EU | Apr 8, 2027 174 days |
| Grant | Enhancing farmer's profitability and resilience through innovations for diversified crops and value chains European Commission · EU | Sep 23, 2027 342 days |
| Grant | Increasing the resilience of agriculture in water and nutrient-scarce environments through digital innovations European Commission · EU | Sep 23, 2027 342 days |
7 · Tech stack & innovations
The stack applies AI-driven control, dexterous touch sensing and direct skeletal attachment to restore lost limb function beyond what traditional socket-and-cable prosthetics can achieve.
- Dexterous touch-sensing hand technology (Dexterous Touch-Sensing Hands):
- Psyonic’s Ability Hand integrates touch sensors precise enough that its data now informs ABB’s industrial robot grasping research, alongside its NVIDIA Isaac Lab integration.
- AI neural prosthetic control (AI Neural Prosthetic Control):
- Atom Limbs combines neural interfaces with AI and advanced robotics to restore natural, intuitive bionic arm movement.
- Myoelectric pattern recognition control (Myoelectric Pattern Recognition):
- Coapt’s COMPLETE CONTROL System Gen2 and Ottobock’s speedhand both use AI/ML-based muscle-signal decoding for multi-grip control, with Coapt’s approach now backed by a dedicated CMS reimbursement code.
- Osseointegration and bone-anchored attachment (Osseointegrated Prostheses):
- Integrum’s OPRA system anchors a prosthesis directly to bone, validated in a Walter Reed National Military Medical Center two-year follow-up study, eliminating socket-related discomfort for eligible amputees.
Sources 6 · 0 independent · 6 producer sites
Producers' own sites 6
- Psyonic producer checked 2026-06-22 · link not kept
- Atom limbs producer checked 2026-02-08 · link not kept
- Coapt producer checked 2026-07-06 · link not kept
- Ottobock producer checked 2026-05-11 · link not kept
- Integrum producer checked 2026-04-16 · link not kept
- Brainco producer checked 2026-07-20 · link not kept